Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Castle Biosciences, Inc./ 10-K

Annual Report · 10-K

Castle Biosciences, Inc.

CSTLNASDAQEQUITYCurrent

Annual Report

Filed Feb 28, 2023Accepted Feb 28, 2023, 5:17 PM ESTCIK 1447362Accession 0001447362-23-000038
View company →Permanent SEC source ↗
Share

Company context

Current securities

CSTLNASDAQ · EQUITY · Current

Recent company filings

  1. 4 filingSep 23, 2026
  2. 4 filingSep 15, 2026
  3. 144 filingSep 14, 2026
  4. 144 filingSep 11, 2026
  5. 4 filingSep 2, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗